About SIMMBION LLC
Unlike popular experimental solutions to the biologics problem based on engineering bacteria, fungi, or viruses, Simmbion’s core technology is based on the synthetic modification of naturally occurring symbionts that safely inhabit millions of people across the globe. Our core technology will engineer symbionts to produce therapeutic agents while avoiding dangerous infections or immune rejection. This will supplant the need for complex manufacturing, repeated injections, long hours of infusions, temperature sensitive storage, high cost of care, and associated compliance issues in a patient-centric, value, and outcome driven healthcare model.
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SIMMBION LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.